Back to top

Image: Bigstock

Intrexon Corporation

Read MoreHide Full Article

Intrexon is focused on developing biologically based products that improve the quality of life. In the fourth quarter of 2015, the company reported a narrower-than-expected loss. Moreover, revenues surpassed expectations. We are positive on the company’s efforts to expand through acquisitions. The company boasts a number of partners including Fibrocell and Merck KGaA. We believe that the company’s core area, the synthetic biology market, holds huge potential. Although, we are positive on its collaborations, unfavorable outcome from any of the development programs could result in a setback for the company, which may even lead to a termination of agreement.